Anlotinib destabilizes PAX3-FOXO1 to induce rhabdomyosarcoma cell death via upregulating NEK2
Open Access
- 10 July 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 117126
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2018YFC1313000)
- National Key Research and Development Program of China (2018YFC1313001)
This publication has 44 references indexed in Scilit:
- Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1Biomedicine & Pharmacotherapy, 2024
- Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeEuropean Journal of Cancer, 2022
- Sangerbox: A comprehensive, interaction‐friendly clinical bioinformatics analysis platformiMeta, 2022
- Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcomaClinical and Translational Oncology, 2019
- Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcomaInternational Journal of Cancer, 2019
- The SCF/c-KIT system in the male: Survival strategies in fertility and cancerMolecular Reproduction and Development, 2014
- Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studiesPediatric Blood & Cancer, 2012
- Regulation of FOXO protein stability via ubiquitination and proteasome degradationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysisInternational Journal of Colorectal Disease, 2011
- Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypesGenes, Chromosomes and Cancer, 2001